logo

For the Inventor, By the Inventor

Raritan, NJ, United States of America

Veridex, Lcc

USPTO Granted Patents = 24

% Expired Patents = 50.0



Forward Citations = 845

Loading Chart...
Loading Chart...

46 inventors (with patents filed for the assignee):

goldMedal Leon W M M Terstappen (10 out of 25 patents)

silverMedal Arjan G J Tibbe (7 out of 10 patents)

bronzeMedal Jan Greve (5 out of 9 patents)

4.  Yixin Wang (5 out of 6 patents)

5.  Galla Chandra Rao (4 out of 21 patents)

6.  Frank P Modica (4 out of 4 patents)

7.  John A Verrant (4 out of 12 patents)

8.  Herman Rutner (3 out of 5 patents)

9.  Madeline I Repollet (3 out of 3 patents)

10.  Frank A W Coumans (3 out of 3 patents)

11.  Mark Carle Connelly (2 out of 15 patents)

12.  Shawn Mark O'Hara (2 out of 5 patents)

13.  Steven Gross (2 out of 4 patents)

14.  Michael Kagan (2 out of 5 patents)

15.  Jerry Prohaska (2 out of 5 patents)


24 patents:

1. 8940493 - Circulating tumor cell assay (2015-01-27),
2. 8569077 - Imaging of immunomagnetically enriched rare cells (2013-10-29),
3. 8337755 - Operator independent programmable sample preparation and analysis system (2012-12-25),
4. 8329422 - Analysis of circulating tumor cells, fragments, and debris (2012-12-11),
5. 8189899 - Methods and algorithms for cell enumeration in a low-cost cytometer (2012-05-29),
6. 8183353 - Breast cancer prognostics (2012-05-22),
7. 8128890 - Methods and algorithms for cell enumeration in a low-cost cytometer (2012-03-06),
8. 8110101 - Method and apparatus for imaging target components in a biological sample using permanent magnets (2012-02-07),
9. 7943397 - Methods and algorithms for cell enumeration in low-cost cytometer (2011-05-17),
10. 7932036 - Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase (2011-04-26),
11. 7927805 - Process for predicting the prognosis of squamous cell lung cancer (2011-04-19),
12. 7901950 - Method for assessing disease states by profile analysis of isolated circulating endothelial cells (2011-03-08),
13. 7863012 - Analysis of circulating tumor cells, fragments, and debris (2011-01-04),
14. 7828968 - Method and apparatus for imaging target components in a biological sample using permanent magnets (2010-11-09),
15. 7815863 - Cartridge for containing a specimen sample for optical analysis (2010-10-19),
Company Overview
Veridex, LLC, based in Raritan, NJ, specializes in the development of advanced diagnostic solutions, particularly in the field of oncology. The company focuses on innovative technologies that enhance the detection and monitoring of cancer, aiming to improve patient outcomes through precision medicine. With a commitment to research and development, Veridex leverages cutting-edge methodologies to provide healthcare professionals with tools that facilitate early diagnosis and effective treatment strategies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Veridex, Lcc USPTO Patent Assignee Logo
24 Patents

#7 in Raritan, NJ

#541 in New Jersey

#13,895 in US

#26,686 in the World

Raritan, NJ (US)
Raritan, NJ, United States of America

Veridex, Lcc

Forward Citations = 845

46 inventors:

goldMedal Leon W M M Terstappen (10 out of 25 patents)

silverMedal Arjan G J Tibbe (7 out of 10 patents)

bronzeMedal Jan Greve (5 out of 9 patents)

4.  Yixin Wang (5 out of 6 patents)

5.  Galla Chandra Rao (4 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Veridex, Lcc. Retrieved from https://idiyas.com/company/veridex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…